首页> 美国卫生研究院文献>BMC Health Services Research >Did the new French pay-for-performance system modify benzodiazepine prescribing practices?
【2h】

Did the new French pay-for-performance system modify benzodiazepine prescribing practices?

机译:法国新的按绩效付费制度是否改变了苯二氮卓的处方做法?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundFrench general practitioners (GPs) were enrolled in a new payment system in January 2012. As part of a national agreement with the French National Ministry of Health, GPs were asked to decrease the proportion of patients who continued their benzodiazepine treatment 12 weeks after its initiation and to decrease the proportion of patients older than 65 who were prescribed long half-life benzodiazepines. In return, GPs could expect an extra payment of up to 490 euros per year. This study reports the evolution of the corresponding prescribing practices of French GPs during that period regarding patients who were prescribed a benzodiazepine for the first time.
机译:背景法国全科医生(GPs)于2012年1月加入了新的支付系统。根据与法国国家卫生部达成的国家协议的一部分,要求GP降低在开始使用苯二氮卓类药物治疗后12周继续接受治疗的患者比例并减少开具长半衰期苯二氮卓类药物的65岁以上患者的比例。作为回报,全科医生可能希望每年额外支付490欧元。这项研究报告了法国GP在此期间针对首次开具苯二氮卓类药物的患者开处方的演变情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号